Merck's request to postpone the next trial over its withdrawn painkiller Vioxx was turned down Monday by a New Jersey judge. Merck had urged the judge to postpone the trial's start for 45 days, citing a "media blitz" after the first trial, which ended Aug. 19 with a Texas jury awarding $253.4 million to the widow of Bob Ernst. Set to start Sept. 12 in Atlantic City, the second trial over the drug involves a man who suffered a heart attack, but survived, four years ago, shortly after he began taking Vioxx.
August 31, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Beleaguered drug maker Merck & Co.’s request to postpone the next trial over its withdrawn painkiller Vioxx was turned down Monday by the New Jersey judge presiding over the case.
Superior Court Judge Carol E. Higbee, who is overseeing nearly 2,500 Vioxx product liability cases that have been filed in New Jersey, also rejected several other Merck motions related to the upcoming trial.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
